| |
|
|
|
ADMA Biologics Inc.  
|
|
4.7 0.36 (0.08%) |
05-22 16:00 |
|
Open: |
4.45 |
Pre close: |
4.34 |
Target:
|
5.70
|
|
High: |
4.74 |
Low: |
4.34 |
Resistance:
|
4.88
5.42
|
|
Volume: |
1,444,935 |
Market Cap: |
271M |
Support:
|
4.00
3.33
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.29
 |
MACD |
MACD(12,26):
|
-0.05 |
|
MA(20): |
4.61  |
Signal(12,26,9): |
-0.00 |
|
MA(100): |
3.96 |
Stochastic Oscillator |
%K(14,3):
|
28.64 |
|
MA(250): |
4.78 |
%D(3): |
17.21 |
|
Average Volume(K) |
3-Month: |
127923
|
52-Week |
High:
|
6.96 |
|
10-Days: |
162396 |
Low: |
2.08 |
|
RSI |
RSI(14):
|
53.32 |
Change(%): |
-10.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.420 |
Return on Equity (ttm) |
-368.9 |
Shares Out. (M) |
46.38 |
|
EPS Est. Current Year |
-1.740 |
Return on Assets (ttm) |
-72.1 |
Shares Float (M) |
46.15 |
|
EPS Est. Next Year |
-1.080 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.50 |
|
EPS Est. Next Quarter |
-0.370 |
Qtrly Rev. Growth |
-12.7 |
% Held by Institutions |
61.40 |
|
Forward EPS |
-0.390 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
19.500 |
EBITDA (p.s.) |
0.000 |
P/E |
-3.31 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.24 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-60.53 |
P/S |
605516672.00 |
|
Operating Margin |
-345.83 |
Levered Free Cash Flow
(M) |
-37.40 |
P/CF |
-3.60 |
|
|
|
|
|
|
